Literature DB >> 16721704

Injectable atypical antipsychotics for agitation in borderline personality disorder.

J C Pascual, M Madre, J Soler, J Barrachina, M J Campins, E Alvarez, V Pérez.   

Abstract

Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16721704     DOI： 10.1055/s-2006-941489

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN： 0176-3679            Impact factor:   5.788


  10 in total

1.  [Inhaled loxapine for emergency treatment of agitated patients with borderline personality disorder : A series of five cases].

Authors:  T H C Krüger; M A Wollmer; P Negt; H Frieling; S Jung; K G Kahl
Journal:  Nervenarzt       Date:  2016-11       Impact factor: 1.214

Review 2.  [Pharmacotherapy of psychiatric acute and emergency situations: General principles].

Authors:  T Messer; F-G Pajonk; M J Müller
Journal:  Nervenarzt       Date:  2015-09       Impact factor: 1.214

3.  Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.

Authors:  Paola Bozzatello; Paola Rocca; Maria Uscinska; Silvio Bellino
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

4.  A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation.

Authors:  Theodore D Satterthwaite; Daniel H Wolf; Robert A Rosenheck; Raquel E Gur; Stanley N Caroff
Journal:  J Clin Psychiatry       Date:  2008-12-02       Impact factor: 4.384

Review 5.  Medications in the treatment of borderline personality disorder 2006.

Authors:  Deanna Mercer
Journal:  Curr Psychiatry Rep       Date:  2007-02       Impact factor: 8.081

6.  State of Acute Agitation at Psychiatric Emergencies in Europe: The STAGE Study.

Authors:  Luis San; Josef Marksteiner; Peter Zwanzger; María Aragüés Figuero; Francisco Toledo Romero; Grigorios Kyropoulos; Alberto Bessa Peixoto; Roxana Chirita; Anca Boldeanu
Journal:  Clin Pract Epidemiol Ment Health       Date:  2016-10-27

Review 7.  Patients with Borderline Personality Disorder in Emergency Departments.

Authors:  Untara Shaikh; Iqra Qamar; Farhana Jafry; Mudasar Hassan; Shanila Shagufta; Yassar Islamail Odhejo; Saeed Ahmed
Journal:  Front Psychiatry       Date:  2017-08-04       Impact factor: 4.157

8.  Remission of Suicidal Ideation in Emotionally Unstable Personality Disorder with Flupenthixol.

Authors:  Daniel J Chivers; Mohammed Shaffiullah
Journal:  Case Rep Psychiatry       Date:  2022-01-13

9.  Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time.

Authors:  Marc Ferrer; Óscar Soto-Angona; María Soler-Artigas; Pol Ibáñez; Christian Fadeuilhe; Raúl Felipe Palma-Álvarez; Raquefet Lidai; Sebastian Vargas-Cáceres; María Ángeles Torrecilla; Anna López; Josep Antoni Ramos-Quiroga
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-08-31       Impact factor: 3.731

10.  Psychotropic medication use in hospitalized patients with borderline personality disorder.

Authors:  Karen E Moeller; Amad Din; Macey Wolfe; Grant Holmes
Journal:  Ment Health Clin       Date:  2016-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.